Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer
Clinical trial NCT00866905 · COMPLETED
Trial details
- NCT number
- NCT00866905
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2014-07-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.